Clinical Trials Directory

Trials / Completed

CompletedNCT03457883

Risk Factors for Recurrence After Pelvic Reconstruction

Risk Factors for Recurrence After Pelvic Reconstruction of Pelvic Organ Prolapse:1 Year Follow-up in Patients Implanted Hernia Mesh and Biological Graft

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
232 (actual)
Sponsor
Nanjing Medical University · Academic / Other
Sex
Female
Age
52 Years – 76 Years
Healthy volunteers
Not accepted

Summary

232 women underwent transvaginal mesh repair (TVM)with /without transvaginal hysterectomy for symptomatic POP, including group A(accepted herniamesh polypropylene mesh, 117 patients);group B (underwent biological graft of cook,115 patients);follow-ups for six months and one year after the surgery and a questionnaire about the life habits associated with relapse.

Detailed description

We prospectively study a total of 232 women who underwent transvaginal mesh repair (TVM)with /without transvaginal hysterectomy for symptomatic POP, the patients into two groups :group A was accepted herniamesh polypropylene mesh(117);group B underwent biological graft of cook(115);Each patient underwent an interview that included a POP-Q which was quantified according to the Pelvic Organ Prolapse Quantitation (POPQ) system;follow-ups for six months and one year after the surgery and a questionnaire about the life habits associated with relapse.

Conditions

Interventions

TypeNameDescription
DEVICEherniameshPatients were randomly assigned in a ratio of 1:1,by using SPSS19.0 statistical software, to either trocar-guided transvaginal mesh(herniamesh, group A) or biological graft (cook, group B)repair.
DEVICEbiological graftPatients were randomly assigned in a ratio of 1:1,by using SPSS19.0 statistical software, to either trocar-guided transvaginal mesh(herniamesh, group A) or biological graft (cook, group B)repair.

Timeline

Start date
2015-01-01
Primary completion
2016-06-01
Completion
2017-12-01
First posted
2018-03-08
Last updated
2018-03-08

Source: ClinicalTrials.gov record NCT03457883. Inclusion in this directory is not an endorsement.